336 results on '"Zhang, Bei B."'
Search Results
2. Branched-chain amino acid catabolism in muscle affects systemic BCAA levels but not insulin resistance
3. GDF15 neutralization restores muscle function and physical performance in a mouse model of cancer cachexia
4. BDK inhibition acts as a catabolic switch to mimic fasting and improve metabolism in mice
5. Regulated dynamic subcellular GLUT4 localization revealed by proximal proteome mapping in human muscle cells
6. Growth differentiation factor 15 neutralization does not impact anorexia or survival in lipopolysaccharide-induced inflammation
7. Pharmacological inhibition of IRAK4 kinase activity does not prevent cachexia in mice with pancreatic cancer
8. GLUT4 dynamic subcellular localization is controlled by AMP kinase activation as revealed by proximal proteome mapping in human muscle cells
9. GLUT4 dynamic subcellular localization is controlled by AMP kinase activation as revealed by proximal proteome mapping in human muscle cells
10. CHAC1 inactivation is effective to preserve muscle glutathione but is insufficient to protect against muscle wasting in cachexia
11. Mice Lacking Dipeptidyl Peptidase IV Are Protected against Obesity and Insulin Resistance
12. The metabolic effects of GDF15 are mediated by the orphan receptor GFRAL
13. Neutralization of GDF15 Prevents Anorexia and Weight Loss in the Monocrotaline-Induced Cardiac Cachexia Rat Model
14. Antidiabetic and antisteatotic effects of the selective fatty acid synthase (FAS) inhibitor platensimycin in mouse models of diabetes
15. A small-molecule glucokinase activator lowers blood glucose in the sulfonylurea-desensitized rat
16. AMPK: An Emerging Drug Target for Diabetes and the Metabolic Syndrome
17. Inhibition of DPP-4 with sitagliptin improves glycemic control and restores islet cell mass and function in a rodent model of type 2 diabetes
18. Suppression of PC-1/ENPP-1 expression improves insulin sensitivity in vitro and in vivo
19. Evidence that inhibition of insulin receptor signaling activity by PC-1/ENPP1 is dependent on its enzyme activity
20. GDF-15 Neutralization Alleviates Platinum-Based Chemotherapy-Induced Emesis, Anorexia, and Weight Loss in Mice and Nonhuman Primates
21. Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin
22. Obesity and genetics regulate microRNAs in islets, liver, and adipose of diabetic mice
23. Cloning and expression of canine glucagon receptor and its use to evaluate glucagon receptor antagonists in vitro and in vivo
24. Abstract 3056: Growth differentiation factor 15 (GDF-15) inhibition attenuates platinum-based chemotherapy-induced emesis, anorexia and weight loss and increases survival
25. Hypothalamic insulin signaling is required for inhibition of glucose production
26. Glucagon and regulation of glucose metabolism
27. A miniaturized cell-based fluorescence resonance energy transfer assay for insulin-receptor activation
28. Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor
29. Small molecule insulin mimetics reduce food intake and body weight and prevent development of obesity
30. FGF21 Analogs of Sustained Action Enabled by Orthogonal Biosynthesis Demonstrate Enhanced Antidiabetic Pharmacology in Rodents
31. Bombesin Receptor Subtype-3 (BRS-3) Regulates Glucose-Stimulated Insulin Secretion in Pancreatic Islets across Multiple Species
32. GDF15 Provides an Endocrine Signal of Nutritional Stress in Mice and Humans
33. Abstract 566: Branched Chain Ketoacid Dehydrogenase Kinase Inhibition Alters Substrate Utilization and Gene Expression in Myocytes
34. Drug Therapy for Insulin Resistance - a Look at the Future
35. PANIC-ATTAC: A Mouse Model for Inducible and Reversible β-Cell Ablation
36. Malonyl CoenzymeA Decarboxylase Regulates Lipid and Glucose Metabolism in Human Skeletal Muscle
37. Ventromedial Hypothalamic Glucokinase Is an Important Mediator of the Counterregulatory Response to Insulin-Induced Hypoglycemia
38. Discovery of small molecule insulin mimetics as potential novel antidiabetic agents
39. Peroxisome Proliferator-Activated Receptor (PPAR)-α Agonism Prevents the Onset of Type 2 Diabetes in Zucker Diabetic Fatty Rats: A Comparison with PPARγ Agonism
40. Differential Role of Multiple Serine Kinases on Fatty Acid-Induced Cellular Insulin Resistance: 2462-PO
41. Glucokinase Activation Directly Enhances Net Hepatic Glucose Uptake during Intraportal Glucose Infusion in Normal Conscious Dogs: 1406-P
42. Mechanism of Nicotinic Acid-Induced Reduction of Glycemic Control and Insulin Resistance in a Mouse Model: 1256-P
43. Chronic Efficacy of a Glucagon Receptor Antagonist in a Diet-Induced Obese Mouse Model: 592-P
44. Direct Comparison of Efficacy and Durability of DPP-4 Inhibitor, PPARγ Agonist and Sulfonylurea on Glycemic Control and β-Cell Function in a Rodent Model of Type 2 Diabetes: 588-P
45. Chronic Inhibition of Dipeptidyl Peptidase-4 With a Sitagliptin Analog Preserves Pancreatic β-Cell Mass and Function in a Rodent Model of Type 2 Diabetes
46. Glucokinase Is a Critical Regulator of Ventromedial Hypothalamic Neuronal Glucosensing
47. Prevention of obesity in mice by antisense oligonucleotide inhibitors of stearoyl-CoA desaturase–1
48. A Novel Glucagon Receptor Antagonist Inhibits Glucagon-Mediated Biological Effects
49. Small-Molecule Insulin Mimetic Reduces Hyperglycemia and Obesity in a Nongenetic Mouse Model of Type 2 Diabetes
50. Hepatic glucagon receptor binding and glucose-lowering in vivo by peptidyl and non-peptidyl glucagon receptor antagonists
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.